Skip to main content

CORRECTION article

Front. Psychol., 20 July 2023
Sec. Psycho-Oncology
Volume 14 - 2023 | https://doi.org/10.3389/fpsyg.2023.1245878
This article is part of the Research Topic Financial Anxiety in Cancer Prevention and Cancer Control View all 10 articles

Corrigendum: Guaranteed Income and Financial Treatment (G.I.F.T.): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes

This article is a correction to:

  1. Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes

    1. Read original article
\r\nMeredith Doherty Meredith Doherty1*Jonathan HeintzJonathan Heintz1Amy LeaderAmy Leader2David WittenburgDavid Wittenburg3Yonatan Ben-ShalomYonatan Ben-Shalom3Jessica JacobyJessica Jacoby1Amy CastroAmy Castro1Stacia WestStacia West4
  • 1School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA, United States
  • 2Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, United States
  • 3Mathematica, Princeton, NJ, United States
  • 4College of Social Work, University of Tennessee, Knoxville, TN, United States

A corrigendum on
Guaranteed Income and Financial Treatment (G.I.F.T.): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes

by Doherty, M., Heintz, J., Leader, A., Wittenberg, D., Ben-Shalom, Y., Jacoby, J., Castro, A., and West, S. (2023). Front. Psychol. 14:1179320. doi: 10.3389/fpsyg.2023.1179320

In the published article, an author name was incorrectly written as David Wittenberg. The correct spelling is David Wittenburg.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cancer, oncology, financial toxicity, income, unconditional cash transfers, randomized controlled trial, social determinants of health

Citation: Doherty M, Heintz J, Leader A, Wittenburg D, Ben-Shalom Y, Jacoby J, Castro A and West S (2023) Corrigendum: Guaranteed Income and Financial Treatment (G.I.F.T.): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes. Front. Psychol. 14:1245878. doi: 10.3389/fpsyg.2023.1245878

Received: 23 June 2023; Accepted: 05 July 2023;
Published: 20 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Doherty, Heintz, Leader, Wittenburg, Ben-Shalom, Jacoby, Castro and West. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Meredith Doherty, bWRvaGVydCYjeDAwMDQwO3VwZW5uLmVkdQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.